UNII PDC6A3C0OX

GLYCERIN

Unique Ingredient Identifier PDC6A3C0OX is listed as a ingredient substance
UniiPDC6A3C0OX
Preferred Substance NameGLYCERIN
Rn56-81-5
Ec200-289-5
NcitC29077
Rxcui4910
Pubchem753
Inn Id444
Molecular FormulaC3H8O3
InchikeyPEDCQBHIVMGVHV-UHFFFAOYSA-N
SmilesOCC(O)CO
Unii TypeINGREDIENT SUBSTANCE
RN56-81-5
EC200-289-5
NCITC29077
RXCUI4910
PUBCHEM753
INN ID444
MFC3H8O3
INCHI KEYPEDCQBHIVMGVHV-UHFFFAOYSA-N
SMILESOCC(O)CO

Alternate Names

Dosage Forms

UNII PDC6A3C0OX GLYCERIN is commonly included in medications in the following forms.

RouteDosage FormPotency
AURICULAR (OTIC)SOLUTION63.64 %
AURICULAR (OTIC)SOLUTION, DROPS2.5 %
AURICULAR (OTIC)SUSPENSION0.05 %
BUCCALGUM, CHEWING28.8 MG
BUCCALPATCH, CONTROLLED RELEASE66 MG
DENTALPASTE NA
DENTALTABLET0.53 MG
IM - IVINJECTION15 %
IM - IV - SCINJECTION15.36 %
IM - IV - SCPOWDER, FOR INJECTION SOLUTION1.2 %
IM - SCINJECTION1.6 %
INHALATIONSOLUTION7.3 %
INTRADERMALINJECTION1.6 %
INTRAMUSCULARINJECTABLE1.78 %W/V
INTRAMUSCULARINJECTION17.81 mg/1mL
INTRAMUSCULARINJECTION15 %
INTRAMUSCULARINJECTION, SOLUTION15 %
INTRAVENOUSEMULSION, INJECTION2.5 %
INTRAVENOUSINJECTABLE2.25 %
INTRAVENOUSINJECTION15 %
INTRAVENOUSINJECTION, EMULSION2.5 %
INTRAVENOUSINJECTION, SOLUTION15 %
INTRAVENOUSSOLUTION, INJECTION18.82 MG/1ML
IONTOPHORESISPATCH, CONTROLLED RELEASE168.1 MG
IV - SCINJECTION1.2 %
IV - SCINJECTION, SOLUTION3.3 MG/1ML
IV(INFUSION)EMULSION NA
IV(INFUSION)EMULSION, INJECTION22.5 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED22.5 %
NASALGEL NA
NASALSOLUTION2.5 %
NASALSPRAY2.3 %
NASALSPRAY, METERED3219.5 MCG/SPRAY
OPHTHALMICDROPS2.25 %
OPHTHALMICEMULSION2.2 %
OPHTHALMICGEL0.88 %
OPHTHALMICSOLUTION20 MG/1ML
OPHTHALMICSOLUTION3 %
OPHTHALMICSUSPENSION2.5 %
OPHTHALMICSUSPENSION, DROPS2.5 %
ORALBAR, CHEWABLE NA
ORALCAPSULE249.1 MG
ORALCAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELAT41 MG
ORALCAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN223.52 MG
ORALCAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL43.85 MG
ORALCAPSULE, COATED, SOFT GELATIN91.5 MG
ORALCAPSULE, DELAYED ACTION NA
ORALCAPSULE, GELATIN COATED3.37 MG
ORALCAPSULE, HARD GELATIN NA
ORALCAPSULE, SOFT GELATIN204.2 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED40 MG
ORALCAPSULE, SUSTAINED ACTION132.32 MG
ORALCONCENTRATE750 MG/1ML
ORALDROPS100 MG/1ML
ORALINJECTION25 MG/1ML
ORALLIQUID885.5 MG/1ML
ORALLIQUID637.5 mg/10mL
ORALORAL SOLUTION DOSAGE FORM500 mg/5mL
ORALSOFT CAPSULE DOSAGE FORM59.14 mg
ORALSOLUTION3077 mg/5mL
ORALSOLUTION1500 mg/15 mL
ORALSOLUTION1249 mg/5 mL
ORALSOLUTION18.64 %W/W
ORALSOLUTION, CONCENTRATE200 MG/1ML
ORALSOLUTION, ELIXIR3108 MG/15ML
ORALSOLUTION, LIQUID222 MG/1ML
ORALSOLUTION, LIQUID, CONCENTRATE, ORAL1010.81 MG/1ML
ORALSOLUTION, SYRUP1235 MG/5ML
ORALSUSPENSION2870.55 MG/5ML
ORALSUSPENSION62.5 mg/1.25mL
ORALSUSPENSION, DROPS250 MG/2.5ML
ORALSUSPENSION, EXTENDED RELEASE100 MG/1ML
ORALSUSPENSION, LIQUID500 MG/1ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION2 %
ORALSYRUP65 %
ORALTABLET16 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED1.4 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE1 MG
ORALTABLET, COATED0.58 MG
ORALTABLET, EXTENDED RELEASE3.64 MG
ORALTABLET, FILM COATED1.55 MG
ORALTABLET, SUSTAINED ACTION3.45 MG
PERFUSION, BILIARYLIQUID2.5 %
RECTALSUPPOSITORY128 MG
SUBCUTANEOUSINJECTABLE2 %
SUBCUTANEOUSINJECTION32.5 %
SUBCUTANEOUSINJECTION, SOLUTION15 %
SUBCUTANEOUSSOLUTION, INJECTION1.9 %
SUBCUTANEOUSSUSPENSION1.6 %
SUBCUTANEOUSSUSPENSION, INJECTION1.6 %
TOPICALAEROSOL3 %W/W
TOPICALCREAM20 %W/W
TOPICALCREAM20 %W/W
TOPICALCREAM, AUGMENTED4 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE3 %W/W
TOPICALDROPS NA
TOPICALEMULSION, AEROSOL FOAM2.11 %W/W
TOPICALEMULSION, CREAM20 %W/W
TOPICALEMULSION, CREAM6 %W/W
TOPICALFILM, CONTROLLED RELEASE2520 MG
TOPICALGEL20 %W/W
TOPICALLIQUID7.2 %W/W
TOPICALLOTION11.2 %W/W
TOPICALOINTMENT NA
TOPICALOPHTHALMIC SUSPENSION DOSAGE FORM0.6 %W/V
TOPICALPATCH2870 MG
TOPICALPATCH, CONTROLLED RELEASE168.1 MG
TOPICALSOLUTION20 MG/1ML
TOPICALSOLUTION11.5 %W/W
TOPICALSPONGE NA
TOPICALSUPPOSITORY, INSERT NA
TOPICALSUSPENSION5 %W/W
TRANSDERMALFILM, CONTROLLED RELEASE306.2 MG
TRANSDERMALGEL5 %W/W
VAGINALCREAM, EMULSION, SUSTAINED RELEASE17 %W/W
VAGINALEMULSION, CREAM5 %W/W
VAGINALGEL14.51 %
VAGINALINSERT22 MG
VAGINALSUPPOSITORY227.9 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.